Novo Nordisk Has High Hopes for Diabetes Blockbuster - Seeking Alpha (blog)
Novo Nordisk Has High Hopes for Diabetes Blockbuster
Seeking Alpha (blog) Novo Nordisk (NVO) has secured US Food and Drug Administration approval for Victoza, its type 2 diabetes treatment for adults. The company, which has waited … STOCKS NEWS EUROPE-Novo Nordisk down after Q4 results Novo Nordisk increased operating profit by 21% in 2009 Novo Nordisk Profit Little Changed on Higher Costs |